JOSHUA FELLER: Open Payments
NPI 1932188638 · EAST LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,364 in 83 payments from 21 companies in 2025. Trend: 2023 $1,142 · 2024 $1,474 · 2025 $1,364
Food & beverage: $1,364
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $184 |
| GlaxoSmithKline, LLC. | 5 | $173 |
| PFIZER INC. | 10 | $166 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $162 |
| Novo Nordisk Inc | 9 | $150 |
| Lilly USA, LLC | 4 | $74 |
| Amgen Inc. | 4 | $72 |
| Vanda Pharmaceuticals Inc. | 2 | $50 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| Medtronic, Inc. | 1 | $39 |
Products named: CAPLYTA, Ozempic, AREXVY, VRAYLAR, MOUNJARO, TRELEGY ELLIPTA, UBRELVY, PREVNAR 20.
Industry payments across MI — which companies pay providers there.
